Literature DB >> 19187401

Initial emergency department systolic blood pressure predicts left ventricular systolic function in acute decompensated heart failure.

Joseph F Styron1, Preeti Jois-Bilowich, Randall Starling, Robert E Hobbs, Michael C Kontos, Peter S Pang, W Frank Peacock.   

Abstract

Ejection fraction (EF) is often unknown in patients who present with acute decompensated heart failure (ADHF). The objective of this study was to determine whether a patient's systolic blood pressure is associated with their left ventricular EF. This study was a retrospective chart review of all patients admitted to an emergency department (ED) observation unit from January 2002 to December 2004. A low EF was defined as <40%. Among 475 patients, the median age was 72 years, 53% were men, 40% were white, 59% were black, and 59% had a low EF. Patients with low EFs were more likely male ( P<.0001), with prior congestive heart disease ( P<.0001), longer QRS duration ( P<.0001), left bundle branch block ( P<.0001), and higher B-type natriuretic peptide ( P<.0001). The low EF group was less likely to have diabetes ( P<.0001). Adjusted odds ratios for an EF >or=40% were significant at all systolic blood pressure readings >120 mm Hg. Having an ED systolic BP >120 mm Hg is associated with significantly higher rates of preserved left ventricular systolic function in patients with ADHF.

Entities:  

Mesh:

Year:  2009        PMID: 19187401     DOI: 10.1111/j.1751-7133.2008.00047.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  2 in total

1.  Optimal dynamic treatment regime estimation using information extraction from unstructured clinical text.

Authors:  Nina Zhou; Robert D Brook; Ivo D Dinov; Lu Wang
Journal:  Biom J       Date:  2022-02-03       Impact factor: 1.715

2.  Control of hypertension in the critically ill: a pathophysiological approach.

Authors:  Diamantino Ribeiro Salgado; Eliezer Silva; Jean-Louis Vincent
Journal:  Ann Intensive Care       Date:  2013-06-27       Impact factor: 6.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.